286 related articles for article (PubMed ID: 18924462)
1. Pharmacoeconomics of subcutaneous allergen immunotherapy.
Incorvaia C; Agostinis F; Amoroso S; Ariano R; Barbato A; Bassi M; Cadario G; Campi P; Cardinale F; Romano C; Ciprandi G; D'Anneo R; Dal Bo S; Di Gioacchino M; Fiocchi A; Galimberti M; Galli E; Giovannini M; La Grutta S; Lombardi C; Marcucci F; Marseglia GL; Mastrandrea F; Minelli M; Nettis E; Novembre E; Ortolani C; Pajno G; Piras PP; Passalacqua G; Patriarca G; Pucci S; Quercia O; Romano A; Schiavino D; Sforza M; Tosca MA; Tripodi S; Zambito M; Puccinelli P; Frati F
Eur Ann Allergy Clin Immunol; 2007; 39 Spec No():17-20. PubMed ID: 18924462
[TBL] [Abstract][Full Text] [Related]
2. Pharmacoeconomic assessment of specific immunotherapy versus current symptomatic treatment for allergic rhinitis and asthma in France.
Omnes LF; Bousquet J; Scheinmann P; Neukirch F; Jasso-Mosqueda G; Chicoye A; Champion L; Fadel R
Eur Ann Allergy Clin Immunol; 2007 May; 39(5):148-56. PubMed ID: 17626329
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of specific subcutaneous immunotherapy in patients with allergic rhinitis and allergic asthma.
Brüggenjürgen B; Reinhold T; Brehler R; Laake E; Wiese G; Machate U; Willich SN
Ann Allergy Asthma Immunol; 2008 Sep; 101(3):316-24. PubMed ID: 18814456
[TBL] [Abstract][Full Text] [Related]
4. Pharmacoeconomics of allergen immunotherapy compared with symptomatic drug treatment in patients with allergic rhinitis and asthma.
Ariano R; Berto P; Tracci D; Incorvaia C; Frati F
Allergy Asthma Proc; 2006; 27(2):159-63. PubMed ID: 16724637
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of specific immunotherapy with Grazax in allergic rhinitis co-existing with asthma.
Nasser S; Vestenbaek U; Beriot-Mathiot A; Poulsen PB
Allergy; 2008 Dec; 63(12):1624-9. PubMed ID: 19032235
[TBL] [Abstract][Full Text] [Related]
6. Cost effectiveness of sublingual immunotherapy in children with allergic rhinitis and asthma.
Berto P; Bassi M; Incorvaia C; Frati F; Puccinelli P; Giaquinto C; Cantarutti L; Ortolani C
Eur Ann Allergy Clin Immunol; 2005 Oct; 37(8):303-8. PubMed ID: 17066648
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of grass allergen tablet (GRAZAX) for the prevention of seasonal grass pollen induced rhinoconjunctivitis - a Northern European perspective.
Bachert C; Vestenbaek U; Christensen J; Griffiths UK; Poulsen PB
Clin Exp Allergy; 2007 May; 37(5):772-9. PubMed ID: 17456225
[TBL] [Abstract][Full Text] [Related]
8. [Clinical efficacy and costs of the three-year specific allergen immunotherapy--retrospective study].
Targowski T; Jahnz-Rózyk K; Przekora P; Kucharczyk A; Owczarek W
Pol Merkur Lekarski; 2011 Aug; 31(182):106-10. PubMed ID: 21936348
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of GRAZAX for prevention of grass pollen induced rhinoconjunctivitis in Southern Europe.
Canonica GW; Poulsen PB; Vestenbaek U
Respir Med; 2007 Sep; 101(9):1885-94. PubMed ID: 17611095
[TBL] [Abstract][Full Text] [Related]
10. Acute coronary syndromes in Europe: 1-year costs and outcomes.
Taylor MJ; Scuffham PA; McCollam PL; Newby DE
Curr Med Res Opin; 2007 Mar; 23(3):495-503. PubMed ID: 17355731
[TBL] [Abstract][Full Text] [Related]
11. Economic aspects of sublingual immunotherapy.
Incorvaia C; Ariano R; Berto P; Ciprandi G; Leo G; Boccardo R; Scurati S; Frati F
Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):27-30. PubMed ID: 19944007
[TBL] [Abstract][Full Text] [Related]
12. The economic costs of severe anaphylaxis in France: an inquiry carried out by the Allergy Vigilance Network.
Flabbee J; Petit N; Jay N; Guénard L; Codreanu F; Mazeyrat R; Kanny G; Moneret-Vautrin DA
Allergy; 2008 Mar; 63(3):360-5. PubMed ID: 18269678
[TBL] [Abstract][Full Text] [Related]
13. Allergen immunotherapy and health care cost benefits for children with allergic rhinitis: a large-scale, retrospective, matched cohort study.
Hankin CS; Cox L; Lang D; Bronstone A; Fass P; Leatherman B; Wang Z
Ann Allergy Asthma Immunol; 2010 Jan; 104(1):79-85. PubMed ID: 20143650
[TBL] [Abstract][Full Text] [Related]
14. Economic evaluation of sublingual immunotherapy: an analysis of literature.
Ciprandi G; Agostinis F; Amoroso S; Ariano R; Barbato A; Bassi M; Cadario G; Campi P; Cardinale F; Romano C; Incorvaia C; Danneo R; Dal Bo S; Di Gioacchino M; Fiocchi A; Galimberti M; Galli E; Giovannini M; La Grutta S; Lombardi C; Marcucci F; Marseglia GL; Mastrandrea F; Minelli M; Nettis E; Novembre E; Ortolani C; Pajno G; Piras PP; Passalacqua G; Patriarca G; Pucci S; Quercia O; Romano A; Schiavino D; Sforza M; Tosca MA; Tripodi S; Zambito M; Puccinelli P; Frati F
Eur Ann Allergy Clin Immunol; 2007; 39 Spec No():21-6. PubMed ID: 18924463
[TBL] [Abstract][Full Text] [Related]
15. [Allergic rhinitis and allergic asthma: SIT saves costs].
Pohlmann BK
Laryngorhinootologie; 2003 Jan; 82(1):68. PubMed ID: 12596723
[No Abstract] [Full Text] [Related]
16. [Cost-of-illness of asthma in Denmark in the year 2000].
Mossing R; Nielsen GD
Ugeskr Laeger; 2003 Jun; 165(26):2646-9. PubMed ID: 12886546
[TBL] [Abstract][Full Text] [Related]
17. Economic evaluation of sublingual immunotherapy vs. symptomatic treatment in allergic asthma.
Ariano R; Berto P; Incorvaia C; Di Cara G; Boccardo R; La Grutta S; Puccinelli P; Frati F
Ann Allergy Asthma Immunol; 2009 Sep; 103(3):254-9. PubMed ID: 19788024
[TBL] [Abstract][Full Text] [Related]
18. Trends in the cost of illness for asthma in the United States, 1985-1994.
Weiss KB; Sullivan SD; Lyttle CS
J Allergy Clin Immunol; 2000 Sep; 106(3):493-9. PubMed ID: 10984369
[TBL] [Abstract][Full Text] [Related]
19. Health-economic analyses of subcutaneous specific immunotherapy for grass pollen and mite allergy.
Petersen KD; Gyrd-Hansen D; Dahl R
Allergol Immunopathol (Madr); 2005; 33(6):296-302. PubMed ID: 16371215
[TBL] [Abstract][Full Text] [Related]
20. Sublingual immunotherapy for treating respiratory allergy: a review on its effectiveness and suitability.
Incorvaia C; Fuiano N; Leo G
Clin Ter; 2010; 161(6):543-7. PubMed ID: 21181085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
